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Conclusion: The implementation of our TOC model has led to 
a higher inclusion in trials, an improved data collection and a 
higher satisfaction of patients and radiation oncologists 
involved in clinical trials. The TOC model has led to an 
optimal infrastructure for well-performed, high-quality 
clinical trials. 
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Purpose or Objective: To report the learning outcomes of a 
standardised national multicentre education program aimed 
at improving General Practitioner (GP) knowledge about 
radiation therapy (RT) and referral pathways to radiation 
oncologists (RO).  
 
Material and Methods: In 2014, a GP education session was 
developed through the ‘Targeting Cancer: Radiation 
Oncology’ campaign (an initiative of RANZCR, Faculty of 
Radiation Oncology). The content and structure was 
developed by a committee of ROs with skills in training and 
education. The sessions are designed to be held within an RT 
department and consist of RO-led interactive teaching around 
two common patient scenarios, followed by a physical tour of 
the RT department with demonstrations of set up and 
treatment. Pre- and immediate post-session custom surveys 
were administered on consented GPs. Four key domains were 
assessed:  
1. Objective and subjective knowledge about RT.  
2. Satisfaction regarding referral pathways to ROs.  
3. Self-reported referral behaviours.  
4. Feedback on quality of the educational session.  
A 6 question follow up survey was sent 6-8 months after the 
session to assess the usefulness of the knowledge gained in 
the clinical care of cancer patients and ongoing referral 
behaviours. 
 
Results: 120 GPs attended a total 10 sessions held in RT 
departments across Australia between October 2014 and 
2015. Pre-session, 96% of GPs reported their knowledge of 
radiation therapy required signficant or some improvement. 
Post-session, 91% rated their knowledge as “excellent”, 
“above average” or “competent”. In concordance with this, 
the proportion of GPs correctly answering objective 
knowledge questions rose from 50% to 82%. Over one third of 
GPs did not know the location of their nearest RT department 
and 80% wanted improved referral pathways to ROs. Despite 
this 92% have had patients in their practice who might 
benefit from palliative RT. However nearly half the GPs 
indicated they were not comfortable referring directly to a 
RO. Following the session this rose to 92%. All 120 
respondents felt the session improved their understanding of 
RT and would recommend the session to colleagues. Early 
data from the 6 month follow up survey shows 100% of GPs 
felt the knowledge gained at the education session has 
improved their ability to care for cancer patients and 
increased their confidence to refer directly to ROs. 
 
Conclusion: A national standardized GP education program 
can significantly improve GP knowledge of the core RT 
concepts and likely influence patient referrals for RT. 
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Purpose or Objective: Population ageing, changes in 
epidemiological trends and the development of new 
treatments are putting strain on National Health Systems, 
which need to implement performance measurement systems 
to minimize the impact of expenditure reduction on service 
quality and to drive value creation for the whole population. 
We developed a model of healthcare performance evaluation 
for oncology care whose main focuses are: - specific types of 
cancers and value for citizens of a catchment area served. 
The model synthesizes into a single index the value of a 
service - outcome and costs for the population – building 
upon the Italian NHS principles. We applied the model to a 
Radiotherapy Service before and after IRST IRCCS took over 
its management in January 2014 
 
Material and Methods: We measured value produced by 
Radiotherapy Services for the Ravenna district (393,184 
inhabitants) before 2013 and after the technological 
investment in 2014.We considered three performance 
dimensions: 
-clinical outcomes; 
-appropriateness; 
-accessibility and geographic proximity of services. 
An expert panel selected variables, indicators and weights 
such as waiting times for treatments, % advanced treatment 
(IMRT, V-MAT), passive migration cases to other areas, 
average access to treatment. Per-capita cost was computed 
as direct costs of radiotherapy minus reimbursement for 
“active” patient migration, plus costs for “passive” patient 
migration; total costs were divided by age-adjusted 
population. A composite indicator was computed, whose 
nominator synthesizes quality indicators and whose 
denominator accounts for costs. 2013 IRST performance in 
Forlì-Cesena district was used as benchmark 
 
Results: Value assessed in Ravenna district was lower than 
that of Forlì-Cesena in 2013 (0.35 and 0.78, respectively), 
translating into a higher per-capita cost (12 euro vs. 9 euro) 
and lower service level (4.2 vs. 7.0 quality points). In 2014, 
performance of Ravenna Radiotherapy Service significantly 
improved (0.47; +34%): quality points went up from 4.2 to 5.1 
as a result of better clinical outcome, improved accessibility 
and shorter wait times Fig1. 
Per-capita costs decreased from 12 Euro to 10.8 Euro thanks 
to a reduction in “passive” patient migration, efficiency gain 
(fewer radiotherapy sessions for specific regimens) and 
economies of scale. A return on investment and financial 
stability were guaranteed by efficiency gain (lower emerging 
compared to savings from reduced “passive” patient 
migration) and by increased attractiveness (increased 
“active” patient migration) Fig2. 
Fig.1 Populational Performance 
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Fig.2 Indicator results 
 
 
Conclusion: Investments in technological upgrades in public 
services can result in increased efficiency and productivity 
levels, while improving service quality, decreasing costs and 
reducing service duplication and overlapping. Our preliminary 
findings suggest the applicability of our model to the full 
cancer care pathway 
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Purpose or Objective: Information and communication 
technologies (ICTs) have enabled cost-effective eHealth 
programmes gain wider acceptance in a range of health 
disciplines. However, this is yet to be evaluated in 
radiotherapy (RT), especially in low- and middle income 
countries (LMICs). We explored the use of ICTs to create a 3-
tier network of teleradiotherapy centres (RTC), namely - 
primary (PRTC) with 1 teletherapy (TRT) unit; secondary 
(SRTC) with 2 TRT units and brachytherapy (BRT); and 
tertiary RT centre (TRTC) with state-of-the-art RT facilities. 
The cost-effectiveness of this network was evaluated for 10 
adjoining countries in middle and east Africa. 
 
Material and Methods: Seven of the 10 countries (Gabon, 
Congo Republic, Congo DR, Central African Republic, South 
Sudan, Rwanda and Burundi) have no RT facilities for their 
123.6 million inhabitants. Remaining 3 countries (Uganda, 
Kenya and Tanzania) have in total 11 TRT and 6 BRT units. 
Thus, presently, only 2.3% of 262.2 million people have RT 
access in these 10 countries. Based on the regional 
population density and location of current centres, 6 PRTCs, 
2 upgraded PRTCs (with BRT), 6 SRTCs and upgradation of an 
existing centre to SRTC are proposed. These could be 
networked to share the available resources. With DICOM RT 
compatible data sets, ICTs could facilitate an easy exchange 
of patient information between centres. Consequently, 
patients at PRTC with a standalone TRT unit could deliver RT 
based on treatment plans derived at SRTC. Similarly patients 
treated at PRTC could receive brachytherapy at SRTC. TRTC 
could cater to specialized RT techniques not feasible either 
at PRTC or SRTC. Thus, patients within the 3-tier network 
would have access to state-of-the-art technology in a shared 
step-wise manner. 
 
Results: The total cost of the infrastructure, networking, 
maintenance and incidentals is estimated around US$ 66.25 
million. With a total of 32 TRT and 15 BRT units provided in 
this network, the RT accessibility would enhance from 2.3% 
to 30.7% (9.2%-76.9%). The mean cost of this investment for 
the 262.2 million inhabitants would be around US$ 0.69 per 
inhabitant (US$ 0.12-2.22) while the average cost in terms of 
individual patients receiving RT is estimated to be US$ 374 
(US$ 71.67-508.33). Capacity building could be undertaken 
through telementoring by linking to regional or international 
centres of excellence and professional societies through 
multisectoral collaborative efforts. 
 
Conclusion: The 3 tier-teletherapy network with ICTs could 
provide cost-effective comprehensive RT care by overcoming 
the geographical barriers by optimizing resource sharing, 
pedagogical telementoring and capacity building. This could 
lead to scalable, equitable, affordable and improved RT 
access to patients of the region. The approach could be 
explored for other underserved LMICs and executed with the 
help of respective national and international stakeholders. 
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Purpose or Objective: MRI offers superior soft tissue 
delineation compared to CT. When incorporated in to a linear 
accelerator (MRI Linac), it could improve temporal resolution 
and dynamic visualisation of the target during treatment 
allowing for motion compensation and real-time adaptive 
planning. This study investigated the predicted patient 
demand for radiotherapy delivered via a MRI Linac for 
prostate and lung cancer at a large comprehensive cancer 
centre to ensure that any clinical research will be 
achievable. 
 
Material and Methods: Local stage data was sourced from 
hospital databases and the UK NHS CASCADE system. 
Indications for MRI Linac were obtained by consulting with 
the specialist clinical leads for prostate and lung cancers. 
Locally advanced patients where soft tissue definition would 
be clinically advantageous were identified (T3/4 prostate, 
stage 2/3 non-small cell lung cancer [NSCLC] including 
superior sulcus tumours and limited stage small cell lung 
cancer [SCLC] with good performance status). The Malthus 
programme was used to estimate the demand for MRI Linac. 
The Malthus programme is an evidence based, predictive 
mathematical model, based on regional population and 
incidence data, mapping around 2,000 clinical decisions 
relating to radiotherapy for 23 different cancer sites. 
 
Results: The catchment area of the comprehensive cancer 
centre in the study is approximately 3.2 million people. For 
prostate, the total projected incidence for 2015 was 1,983 
cases, of which 436 high risk patients were predicted to be 
eligible for MRI Linac. For lung, the total projected incidence 
for 2015 is 2,634 cases. Of these, a total of 360 patients were 
identified as suitable for MRI Linac (table 1). Approximately 
92 of the NSCLC’s were considered superior sulcus tumours. 
